| CAT No: | CL-RMCN-07 |
| CAS No: | 148554-65-8 |
| Mol.F: | C51H79NO13 : Na |
| Mol.Wt.: | 914.2 : 23.0 |
| Rel. Cas No: | |
| Chemical Name: | (S)-1-(2-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid, sodium salt |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to Seco Rapamycin Sodium salt is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Seco Rapamycin Sodium salt is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(S)-1-(2-((2R,3R,6S)-2-hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid, sodium saltCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Rapamycin Molecular Formula: C51H79NO13 : Na
Molecular Weight: 914.2 : 23.0
Storage: Store in a cool, dry place.
| Product Name: | Seco Rapamycin Sodium salt |
| CAS No: | 148554-65-8 |
| Mol.F.: | C51H79NO13 : Na |
| Mol.Wt.: | 914.2 : 23.0 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: